Press release
RSV Diagnostics Market Set to Surge Significantly During 2019
Many clinics perform antigen detection test for diagnosis of human respiratory syncytial virus infection. In most of the cases, results of antigen detection tests are validated by cell culture tests. Antigen detection testsare 80% to 90% more sensitive than cell culture test for detection of RSV infection. Currently, reverse transcriptase polymerase chain reaction (RT-PCR) kits are also available in the market for the detection of human respiratory syncytial virus. Though serological tests are available in the market, they are less frequently used for routine diagnosis. Furthermore,based on the type of end users, The RSV Diagnosis Market is segmented as follows: Hospitals, Physicians’ offices, Commercial labs, Private Labs.
Request to View Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2080
Some of the major companies contributing to global RSV diagnostics market are Becton, Dickinson and Company, Abbott Laboratories, Alere, Inc., Quidel Corporation, and Focus Diagnostics, Inc.
Pre-Book Full Report -
https://www.transparencymarketresearch.com/checkout.php?rep_id=2080<ype=S
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release RSV Diagnostics Market Set to Surge Significantly During 2019 here
News-ID: 879439 • Views: …
More Releases from Transparency Market Research
Neurology Diagnostic and Monitoring Devices Market to Reach Over $12.4 Billion b …
The neurology diagnostic and monitoring devices market represents one of the most rapidly evolving segments in the global medical device industry as healthcare systems worldwide intensify their focus on early detection and management of neurological disorders. This market includes a wide spectrum of technologies-ranging from advanced neuroimaging systems to electrophysiological monitoring devices-designed to diagnose conditions such as epilepsy, stroke, dementia, traumatic brain injuries, neuromuscular diseases, and brain tumors. With neurological…
North America Hardwood Market Outlook 2031: Accelerating Demand, Sustainable For …
The North America hardwood market is entering a period of significant expansion, backed by rising construction activities, robust demand from the furniture and cabinetry sector, and a strengthening shift toward sustainable forestry and certified wood products. With the industry valued at US$ 42.5 billion in 2022, the market is forecast to grow at a CAGR of 7.2% from 2023 to 2031, ultimately reaching US$ 79.9 billion by 2031. As hardwood…
North America Garage Storage Market Outlook 2034: Strategic Growth Trends, Organ …
The North America garage storage market is undergoing a noticeable transformation as homeowners increasingly prioritize functional living spaces, home organization, and value-added property improvements. With the industry valued at US$ 4.9 billion in 2023, the market is expected to expand steadily at a CAGR of 5.2% from 2024 to 2034, ultimately reaching US$ 7.6 billion by 2034. The growing focus on maximizing storage capacity, enhancing home aesthetics, and integrating smart,…
North America Candle Market Poised for Growth to US$ 8.0 Bn by 2031 amid Rising …
The North America Candle Market continues to expand steadily, driven by rising consumer interest in home ambiance, aromatherapy, lifestyle décor, and wellness-oriented products. Candles have evolved beyond basic illumination to become a core component of interior aesthetics, personal relaxation routines, festive celebrations, and gift culture. The market is particularly strong in the U.S. and Canada, where consumers show high willingness to invest in scented, decorative, natural, and premium candles across…
More Releases for RSV
The Rise In The Prevalence Of RSV Infection : A Key Catalyst Accelerating Global …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Respiratory Syncytial Virus (RSV) Therapeutics Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market encompassing therapeutics for respiratory syncytial virus (rsv) has witnessed substantial, rapid expansion lately, projected to increase its valuation from $1.6 billion in 2024 to $2 billion just one year later…
The Rise In The Prevalence Of RSV Infection : Transformative Forces Shaping the …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Respiratory Syncytial Virus (RSV) Therapeutics Industry Market Size Be by 2025?
The market size for therapeutics treating the respiratory syncytial virus (RSV) has seen significant expansion in the past few years. It is expected to surge from $1.6 billion in 2024 to $2 billion in 2025,…
RSV Vaccine Market To Reach 731 million by 2040, Due To Increasing Awareness on …
According to our latest market report "RSV Vaccine Market, Till 2040 by Type of Vaccine, Route of Administration, Target Patient Population, Distribution Channel, Key Geographical Regions and Leading Players", the RSV Vaccine market size is projected to reach USD 731 million by 2040 from USD 1,149 million in current year, during the forecast period.
To request quote of this report, please visit:
https://www.rootsanalysis.com/reports/rsv-vaccine-market/request-quote.html
In the dynamic landscape of preventive therapies for respiratory…
Global RSV Diagnostic Products Market Size & Trends
According to a new market research report published by Global Market Estimates, the global RSV diagnostic products market is expected to grow at a CAGR of 11.4% from 2023 to 2028.
Ongoing advancements in diagnostic technologies, specifically PCR and rapid point-of-care testing, play a crucial role. These advancements offer heightened accuracy, faster results, and increased accessibility, enabling prompt and precise identification of RSV infections.
Browse 147 Market Data Tables and 115 Figures…
Respiratory Syncytial Virus (RSV) Therapeutics Market Size to Reach USD 9080.84 …
Respiratory Syncytial Virus (RSV) Therapeutics Market Scope & Overview
Respiratory Syncytial Virus (RSV) Therapeutics Market size was USD 1040.65 Million in 2022 and is expected to Reach USD 9080.84 Million by 2030 and grow at a CAGR of 31.1% over the forecast period of 2023-2030.
The Respiratory Syncytial Virus (RSV) Therapeutics market is a vibrant, fiercely competitive sector that is essential to digital marketing. The demand for effective has increased as companies…
Respiratory Syncytial Virus (RSV) Therapeutics Market - Conquering RSV: Advancin …
Newark, New Castle, USA: The "Respiratory Syncytial Virus (RSV) Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Respiratory Syncytial Virus (RSV) Therapeutics Market: https://www.growthplusreports.com/report/respiratory-syncytial-virus-rsv-therapeutics-market/8519
This latest report…
